Emphasis will be placed on Innovative Projects Focused on Solutions for COVID-19 and other Infectious Disease
RICHMOND, VA – April 1, 2020 – The Virginia Catalyst, formerly known as the Virginia Biosciences Health Research Corporation (VBHRC), today announced that it is accepting letters of intent (LOI) for Grant Round 11 to fund the development and commercialization of life science projects that address major unmet needs for improving human health and advancing Virginia’s economy.
While all life science projects will be accepted for Grant Round 11, given the impact of COVID-19, emphasis will be placed on projects within the areas of infectious disease, immunology, vaccine and drug discovery, and innovative service delivery models including telehealth and telemedicine.
Read the full article here
Your comment will be posted after it is approved.
Leave a Reply.